Lindbrook Capital’s AnaptysBio ANAB Stock Holding History

Lindbrook Capital’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$223	Sell	12 -30	-71%	-$500	﹤0.01%	2699
2024 Q4	$556	Sell	42 -61	-59%	-$1.48K	﹤0.01%	2593
2024 Q3	$3.45K	Sell	103 -220	-68%	-$7.52K	﹤0.01%	2160
2024 Q2	$8.09K	Buy	323 +281	+669%	+$6.54K	﹤0.01%	1748
2024 Q1	$946	Hold	42	–	–	﹤0.01%	2433
2023 Q4	$900	Sell	42 -38	-48%	-$655	﹤0.01%	2489
2023 Q3	$1.44K	Buy	80 +23	+40%	+$439	﹤0.01%	2237
2023 Q2	$1.16K	Sell	57 -6	-10%	-$122	﹤0.01%	2337
2023 Q1	$1.37K	Sell	63 -214	-77%	-$5.2K	﹤0.01%	2380
2022 Q4	$8.58K	Hold	277	–	–	﹤0.01%	1511
2022 Q3	$7K	Buy	277 +190	+218%	+$4.45K	﹤0.01%	1468
2022 Q2	$2K	Buy	87 +45	+107%	+$997	﹤0.01%	1902
2022 Q1	$1K	Hold	42	–	–	﹤0.01%	2156
2021 Q4	$1K	Hold	42	–	–	﹤0.01%	1873
2021 Q3	$1K	Hold	42	–	–	﹤0.01%	1668
2021 Q2	$1K	Hold	42	–	–	﹤0.01%	1700
2021 Q1	$1K	Hold	42	–	–	﹤0.01%	1664
2020 Q4	$1K	Hold	42	–	–	﹤0.01%	1565
2020 Q3	$1K	Hold	42	–	–	﹤0.01%	1502
2020 Q2	$1K	Hold	42	–	–	﹤0.01%	1507
2020 Q1	$1K	Buy	+42	New	+$637	﹤0.01%	1381

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lindbrook Capital's ANAB Position: Q1 2025 in Review

Lindbrook Capital reduced its AnaptysBio (ANAB) stake by 71% in Q1 2025, selling an estimated $500 and leaving 12 shares worth $223. The position accounts for ﹤0.01% of the portfolio, ranked #2699.

Lindbrook Capital first reported a position in ANAB in Q1 2020 and has held it in 21 quarters since. The position peaked at $8.58K in Q4 2022. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

Lindbrook Capital held 12 shares of AnaptysBio worth $223 as of Q1 2025.
Lindbrook Capital sold 30 AnaptysBio shares in Q1 2025, an estimated $500.
AnaptysBio made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2699 holding.
Lindbrook Capital first reported a position in AnaptysBio in Q1 2020 and has held it in 21 quarters since.
Lindbrook Capital's AnaptysBio position peaked at $8.58K in Q4 2022.
153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.